These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 33037466
21. TRKA expression and NTRK1 gene copy number across solid tumours. Mauri G, Valtorta E, Cerea G, Amatu A, Schirru M, Marrapese G, Fiorillo V, Recchimuzzo P, Cavenago IS, Bonazzina EF, Motta V, Lauricella C, Veronese S, Tosi F, Maiolani M, Rospo G, Truini M, Bonoldi E, Christiansen J, Potts SJ, Siena S, Sartore-Bianchi A. J Clin Pathol; 2018 Oct; 71(10):926-931. PubMed ID: 29802225 [Abstract] [Full Text] [Related]
22. Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion. Ren H, Hou X, Eiken PW, Zhang J, Pierson KE, Nair AA, Davila JI, Kovarikova H, Jang JS, Johnson SH, Molina JR, Marks RS, Yang P, Yi JE, Mansfield AS, Jen J. Clin Lung Cancer; 2019 Mar; 20(2):e142-e147. PubMed ID: 30581091 [No Abstract] [Full Text] [Related]
23. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, Giedl J, Carbon R, Rompel O, Hartmann A, Wiemann S, Metzler M, Agaimy A. J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915 [Abstract] [Full Text] [Related]
24. N of 2 Responders with LMNA-NTRK1. Lih CJ, Chen AP. J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563357 [No Abstract] [Full Text] [Related]
25. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma. Yu Z, Wang H, Song Q, Huang J, Xu J, Su J, Wang H, Tan L, Wang X, Jiang Z, Chen W, Jiang D, Hou Y. J Cancer Res Clin Oncol; 2021 Oct; 147(10):3113-3121. PubMed ID: 33963905 [Abstract] [Full Text] [Related]
26. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment. Chen W, Wang H, Jiang D, Luan L, Zhou Y, Hou Y. World J Surg Oncol; 2021 Apr 30; 19(1):136. PubMed ID: 33941195 [Abstract] [Full Text] [Related]
27. MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC. Fang W, Gan J, Hong S, Lu F, Zhang L. J Thorac Oncol; 2019 Jul 30; 14(7):e148-e151. PubMed ID: 31235041 [No Abstract] [Full Text] [Related]
28. Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification. Zhong L, Zhang C, Jia W, Zhang P. Ann Diagn Pathol; 2021 Apr 30; 51():151700. PubMed ID: 33465722 [Abstract] [Full Text] [Related]
29. Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma. Kim TH, Buonocore D, Petre EN, Durack JC, Maybody M, Johnston RP, Travis WD, Adusumilli PS, Solomon SB, Ziv E. Ann Thorac Surg; 2019 Aug 30; 108(2):392-398. PubMed ID: 30986416 [Abstract] [Full Text] [Related]
30. A rare case of an EML4-ALK-rearranged lung adenocarcinoma missed by in situ-hybridization but detected by RT-PCR. Roth A, Streubel A, Grah C, Stephan-Falkenau S, Mairinger T, Wagner F. J Clin Pathol; 2014 Sep 30; 67(9):839-40. PubMed ID: 25028527 [No Abstract] [Full Text] [Related]
31. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma. Feng T, Chen Z, Gu J, Wang Y, Zhang J, Min L. Lung Cancer; 2019 Nov 30; 137():19-22. PubMed ID: 31521978 [Abstract] [Full Text] [Related]
32. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions. Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M. Clin Cancer Res; 2012 Dec 15; 18(24):6599-608. PubMed ID: 23052255 [Abstract] [Full Text] [Related]
33. TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. Albert CM, Davis JL, Federman N, Casanova M, Laetsch TW. J Clin Oncol; 2019 Feb 20; 37(6):513-524. PubMed ID: 30592640 [Abstract] [Full Text] [Related]
34. Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing. Zhu YC, Wang WX, Xu CW, Zhang QX, Du KQ, Chen G, Lv TF, Song Y. Ann Oncol; 2018 Dec 01; 29(12):2392-2393. PubMed ID: 30339198 [No Abstract] [Full Text] [Related]
35. Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion-Positive Tumor Cells in a Brain Metastasis Model. Nishiyama A, Yamada T, Kita K, Wang R, Arai S, Fukuda K, Tanimoto A, Takeuchi S, Tange S, Tajima A, Furuya N, Kinoshita T, Yano S. Clin Cancer Res; 2018 May 15; 24(10):2357-2369. PubMed ID: 29463555 [Abstract] [Full Text] [Related]
36. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes. Roccato E, Bressan P, Sabatella G, Rumio C, Vizzotto L, Pierotti MA, Greco A. Cancer Res; 2005 Apr 01; 65(7):2572-6. PubMed ID: 15805251 [Abstract] [Full Text] [Related]
37. The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B-NTRK1 fusion. Shinozaki-Ushiku A, Ishikawa S, Komura D, Seto Y, Aburatani H, Ushiku T. Gastric Cancer; 2020 Sep 01; 23(5):944-947. PubMed ID: 32189226 [Abstract] [Full Text] [Related]
38. A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications. Rekhi B, Shetty O, Bapat P, Gurav M, Qureshi S. Int J Surg Pathol; 2021 Feb 01; 29(1):102-108. PubMed ID: 32489127 [Abstract] [Full Text] [Related]
39. Resected High-Risk Rectal GIST Harboring NTRK1 Fusion: a Case Report and Review of the Literature. D'Alpino Peixoto R, Medeiros BA, Cronemberger EH. J Gastrointest Cancer; 2021 Mar 01; 52(1):316-319. PubMed ID: 32506289 [No Abstract] [Full Text] [Related]
40. A Case of a Pregnant Woman Diagnosed as Having ALK-rearranged Lung Adenocarcinoma. Komura M, Yagishita S, Nakamura K, Arano N, Takeshige T, Muraki K, Nagashima O, Izumi H, Tomita S, Sasaki S, Takahashi K. In Vivo; 2018 Mar 01; 32(5):1205-1209. PubMed ID: 30150445 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]